Foscarnet.
Zeichner
S L
SL
HIV and AIDS Malignancy Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
D000998:Antiviral Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D017726:Cytomegalovirus Retinitis / Q000188:drug therapy; D017245:Foscarnet / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006566:Herpesviridae Infections / Q000188:drug therapy; D006801:Humans
D000998:Antiviral Agents; D017245:Foscarnet